共 162 条
[1]
Ramzy D(2020)New circulatory support system outcomes ASAIO J 66 746-752
[2]
Soltesz E(2019)Management of anticoagulation with Impella® percutaneous ventricular assist devices and review of new literature J Thromb Thrombolysis 48 284-291
[3]
Anderson M(2020)The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support Circulation 141 273-284
[4]
Succar L(2018)Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device Am Heart J 202 33-38
[5]
Sulaica EM(2018)The cVAD registry for percutaneous temporary hemodynamic support: a prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure Am Heart J 199 115-121
[6]
Donahue KR(2019)Improved outcomes associated with the use of shock protocols: Updates from the national cardiogenic shock initiative Catheter Cardiovasc Interv 93 1173-1183
[7]
Wanat MA(2019)Rationale and design of DanGer shock: Danish-German cardiogenic shock trial Am Heart J 214 60-68
[8]
Amin AP(2019)Clinical outcomes of Impella microxial devices used to salvage cardiogenic shock as a bridge to durable circulatory support or cardiac transplantation ASAIO J 65 642-648
[9]
Spertus JA(2020)Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device Clin Transpl 34 e13818-25
[10]
Curtis JP(2017)Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis Eur J Cardiothorac Surg 52 14-156